Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
Can you use a JAK inhibitor and Mavenclad in a patient with both multiple sclerosis and rheumatoid arthritis?
Related Questions
Do you treat tumefactive multiple sclerosis differently than other forms of MS both in the acute and maintenance phase?
How do you counsel women on anti-CD20 therapy for MS who are planning for pregnancy?
How would you manage a patient with LGI-1 encephalitis with faciobracial dystonic seizures who has not improved with 3 days of intravenous steroids?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
When do you consider pembrolizumab for the treatment of progressive multifocal leukoencephalopathy?
What are red flags in an evaluation for possible multiple sclerosis that should prompt workup for genetic/inherited conditions?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
What is your treatment approach to neuropsychiatric symptoms secondary to lupus?
Would you proceed with anti-CD20 treatment in an MS patient who is VZV IgG negative in spite of vaccination in the last year?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
